nodes	percent_of_prediction	percent_of_DWPC	metapath
Baclofen—SLC22A8—Conjugated Estrogens—osteoporosis	0.229	0.532	CbGbCtD
Baclofen—SLC22A8—Estradiol—osteoporosis	0.201	0.467	CbGbCtD
Baclofen—GABBR2—Activation of GABAB receptors—ADCY5—osteoporosis	0.00411	0.0538	CbGpPWpGaD
Baclofen—Chlorphenesin—CYP19A1—osteoporosis	0.00382	1	CrCbGaD
Baclofen—GABBR2—GABA receptor activation—ADCY5—osteoporosis	0.00315	0.0412	CbGpPWpGaD
Baclofen—GABBR1—Activation of GABAB receptors—ADCY5—osteoporosis	0.00265	0.0347	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—PTH1R—osteoporosis	0.00212	0.0278	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—CALCR—osteoporosis	0.00212	0.0278	CbGpPWpGaD
Baclofen—GABBR1—GABA receptor activation—ADCY5—osteoporosis	0.00203	0.0266	CbGpPWpGaD
Baclofen—GABBR2—G alpha (i) signalling events—CNR2—osteoporosis	0.0018	0.0235	CbGpPWpGaD
Baclofen—GABBR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	0.00145	0.019	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—PTH1R—osteoporosis	0.00137	0.0179	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—CALCR—osteoporosis	0.00137	0.0179	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—CALCR—osteoporosis	0.0012	0.0157	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—PTH1R—osteoporosis	0.0012	0.0157	CbGpPWpGaD
Baclofen—GABBR1—G alpha (i) signalling events—CNR2—osteoporosis	0.00116	0.0152	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—PTH—osteoporosis	0.00112	0.0146	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—CALCR—osteoporosis	0.00109	0.0143	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PTH1R—osteoporosis	0.00109	0.0143	CbGpPWpGaD
Baclofen—GABBR2—Transmission across Chemical Synapses—ADCY5—osteoporosis	0.00109	0.0143	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—CNR2—osteoporosis	0.00109	0.0142	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—WNT1—osteoporosis	0.00102	0.0134	CbGpPWpGaD
Baclofen—GABBR2—G alpha (i) signalling events—ADCY5—osteoporosis	0.000956	0.0125	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—MGLL—osteoporosis	0.000953	0.0125	CbGpPWpGaD
Baclofen—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	0.000932	0.0122	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—PTHLH—osteoporosis	0.000924	0.0121	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—MGLL—osteoporosis	0.000866	0.0113	CbGpPWpGaD
Baclofen—GABBR2—Neuronal System—ADCY5—osteoporosis	0.000833	0.0109	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—CALCA—osteoporosis	0.000814	0.0107	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—PTH1R—osteoporosis	0.000773	0.0101	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—CALCR—osteoporosis	0.000773	0.0101	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—PTH—osteoporosis	0.000719	0.00942	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—SOST—osteoporosis	0.000712	0.00933	CbGpPWpGaD
Baclofen—GABBR2—G alpha (i) signalling events—POMC—osteoporosis	0.000703	0.00921	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—CALCR—osteoporosis	0.000702	0.0092	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PTH1R—osteoporosis	0.000702	0.0092	CbGpPWpGaD
Baclofen—GABBR1—Transmission across Chemical Synapses—ADCY5—osteoporosis	0.000701	0.00918	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—CNR2—osteoporosis	0.000701	0.00918	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—WNT1—osteoporosis	0.000659	0.00863	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PTH1R—osteoporosis	0.000644	0.00844	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CALCR—osteoporosis	0.000644	0.00844	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—PTH—osteoporosis	0.00063	0.00826	CbGpPWpGaD
Baclofen—GABBR1—G alpha (i) signalling events—ADCY5—osteoporosis	0.000616	0.00807	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—MGLL—osteoporosis	0.000614	0.00805	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—CNR2—osteoporosis	0.000614	0.00805	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—PTHLH—osteoporosis	0.000596	0.00781	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PTH—osteoporosis	0.000572	0.0075	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—MGLL—osteoporosis	0.000558	0.00731	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—CNR2—osteoporosis	0.000558	0.00731	CbGpPWpGaD
Baclofen—GABBR1—Neuronal System—ADCY5—osteoporosis	0.000537	0.00704	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—WNT1—osteoporosis	0.000525	0.00687	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—CALCA—osteoporosis	0.000524	0.00687	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—PTHLH—osteoporosis	0.000522	0.00684	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MGLL—osteoporosis	0.000511	0.0067	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—LRP5—osteoporosis	0.000499	0.00654	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—LRP6—osteoporosis	0.000477	0.00626	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PTHLH—osteoporosis	0.000474	0.00622	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—CALCA—osteoporosis	0.00046	0.00603	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SOST—osteoporosis	0.000459	0.00601	CbGpPWpGaD
Baclofen—GABBR1—G alpha (i) signalling events—POMC—osteoporosis	0.000453	0.00594	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—POMC—osteoporosis	0.000426	0.00558	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—CALCA—osteoporosis	0.000418	0.00547	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CALCR—osteoporosis	0.000415	0.00544	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PTH1R—osteoporosis	0.000415	0.00544	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—PTH—osteoporosis	0.000406	0.00532	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—TLN1—osteoporosis	0.000403	0.00528	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—CNR2—osteoporosis	0.000396	0.00519	CbGpPWpGaD
Baclofen—Asthenia—Estropipate—osteoporosis	0.000383	0.000781	CcSEcCtD
Baclofen—Visual impairment—Estradiol—osteoporosis	0.000383	0.000781	CcSEcCtD
Baclofen—Anorexia—Pamidronate—osteoporosis	0.000382	0.00078	CcSEcCtD
Baclofen—Myalgia—Zoledronate—osteoporosis	0.000382	0.00078	CcSEcCtD
Baclofen—Chest pain—Zoledronate—osteoporosis	0.000382	0.00078	CcSEcCtD
Baclofen—Palpitations—Conjugated Estrogens—osteoporosis	0.000382	0.000779	CcSEcCtD
Baclofen—Insomnia—Risedronate—osteoporosis	0.000382	0.000779	CcSEcCtD
Baclofen—Anxiety—Zoledronate—osteoporosis	0.000381	0.000777	CcSEcCtD
Baclofen—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.00038	0.000775	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.00038	0.000774	CcSEcCtD
Baclofen—Paraesthesia—Risedronate—osteoporosis	0.000379	0.000773	CcSEcCtD
Baclofen—Pruritus—Estropipate—osteoporosis	0.000378	0.000771	CcSEcCtD
Baclofen—Discomfort—Zoledronate—osteoporosis	0.000378	0.00077	CcSEcCtD
Baclofen—Asthenia—Alendronate—osteoporosis	0.000377	0.00077	CcSEcCtD
Baclofen—Dyspnoea—Risedronate—osteoporosis	0.000376	0.000767	CcSEcCtD
Baclofen—Hypotension—Pamidronate—osteoporosis	0.000375	0.000765	CcSEcCtD
Baclofen—Convulsion—Conjugated Estrogens—osteoporosis	0.000375	0.000764	CcSEcCtD
Baclofen—Dry mouth—Zoledronate—osteoporosis	0.000374	0.000763	CcSEcCtD
Baclofen—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000374	0.000762	CcSEcCtD
Baclofen—Fatigue—Ethinyl Estradiol—osteoporosis	0.000373	0.000761	CcSEcCtD
Baclofen—Pruritus—Alendronate—osteoporosis	0.000372	0.000759	CcSEcCtD
Baclofen—Dyspepsia—Risedronate—osteoporosis	0.000371	0.000758	CcSEcCtD
Baclofen—Eye disorder—Estradiol—osteoporosis	0.000371	0.000758	CcSEcCtD
Baclofen—Tinnitus—Estradiol—osteoporosis	0.000371	0.000756	CcSEcCtD
Baclofen—Constipation—Ethinyl Estradiol—osteoporosis	0.00037	0.000755	CcSEcCtD
Baclofen—Confusional state—Zoledronate—osteoporosis	0.000369	0.000754	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—PTH—osteoporosis	0.000369	0.00483	CbGpPWpGaD
Baclofen—Cardiac disorder—Estradiol—osteoporosis	0.000369	0.000752	CcSEcCtD
Baclofen—Flushing—Estradiol—osteoporosis	0.000369	0.000752	CcSEcCtD
Baclofen—Chest pain—Conjugated Estrogens—osteoporosis	0.000368	0.000751	CcSEcCtD
Baclofen—Myalgia—Conjugated Estrogens—osteoporosis	0.000368	0.000751	CcSEcCtD
Baclofen—Asthenia—Ibandronate—osteoporosis	0.000367	0.000749	CcSEcCtD
Baclofen—Anxiety—Conjugated Estrogens—osteoporosis	0.000367	0.000748	CcSEcCtD
Baclofen—Nausea—Etidronic acid—osteoporosis	0.000367	0.000748	CcSEcCtD
Baclofen—Oedema—Zoledronate—osteoporosis	0.000366	0.000747	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000365	0.000746	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000365	0.000746	CcSEcCtD
Baclofen—Diarrhoea—Estropipate—osteoporosis	0.000365	0.000745	CcSEcCtD
Baclofen—Gastrointestinal disorder—Risedronate—osteoporosis	0.000364	0.000743	CcSEcCtD
Baclofen—Infection—Zoledronate—osteoporosis	0.000364	0.000743	CcSEcCtD
Baclofen—Fatigue—Risedronate—osteoporosis	0.000364	0.000742	CcSEcCtD
Baclofen—Insomnia—Pamidronate—osteoporosis	0.000363	0.00074	CcSEcCtD
Baclofen—Pruritus—Ibandronate—osteoporosis	0.000362	0.000739	CcSEcCtD
Baclofen—Constipation—Risedronate—osteoporosis	0.000361	0.000736	CcSEcCtD
Baclofen—Pain—Risedronate—osteoporosis	0.000361	0.000736	CcSEcCtD
Baclofen—Angiopathy—Estradiol—osteoporosis	0.000361	0.000736	CcSEcCtD
Baclofen—Shock—Zoledronate—osteoporosis	0.00036	0.000735	CcSEcCtD
Baclofen—Paraesthesia—Pamidronate—osteoporosis	0.00036	0.000735	CcSEcCtD
Baclofen—Diarrhoea—Alendronate—osteoporosis	0.00036	0.000734	CcSEcCtD
Baclofen—Asthenia—Calcitriol—osteoporosis	0.00036	0.000734	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—CNR2—osteoporosis	0.000359	0.00471	CbGpPWpGaD
Baclofen—Nervous system disorder—Zoledronate—osteoporosis	0.000359	0.000733	CcSEcCtD
Baclofen—Mediastinal disorder—Estradiol—osteoporosis	0.000358	0.000731	CcSEcCtD
Baclofen—Dyspnoea—Pamidronate—osteoporosis	0.000358	0.00073	CcSEcCtD
Baclofen—Tachycardia—Zoledronate—osteoporosis	0.000358	0.000729	CcSEcCtD
Baclofen—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000357	0.000728	CcSEcCtD
Baclofen—Chills—Estradiol—osteoporosis	0.000357	0.000727	CcSEcCtD
Baclofen—Somnolence—Pamidronate—osteoporosis	0.000357	0.000727	CcSEcCtD
Baclofen—Skin disorder—Zoledronate—osteoporosis	0.000356	0.000726	CcSEcCtD
Baclofen—Pruritus—Calcitriol—osteoporosis	0.000355	0.000723	CcSEcCtD
Baclofen—Hyperhidrosis—Zoledronate—osteoporosis	0.000354	0.000723	CcSEcCtD
Baclofen—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000354	0.000722	CcSEcCtD
Baclofen—Diarrhoea—Raloxifene—osteoporosis	0.000354	0.000722	CcSEcCtD
Baclofen—SLC22A8—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000353	0.00463	CbGpPWpGaD
Baclofen—Dyspepsia—Pamidronate—osteoporosis	0.000353	0.00072	CcSEcCtD
Baclofen—Dizziness—Estropipate—osteoporosis	0.000353	0.00072	CcSEcCtD
Baclofen—Oedema—Conjugated Estrogens—osteoporosis	0.000353	0.00072	CcSEcCtD
Baclofen—Alopecia—Estradiol—osteoporosis	0.000351	0.000716	CcSEcCtD
Baclofen—Infection—Conjugated Estrogens—osteoporosis	0.000351	0.000715	CcSEcCtD
Baclofen—Diarrhoea—Ibandronate—osteoporosis	0.00035	0.000715	CcSEcCtD
Baclofen—Anorexia—Zoledronate—osteoporosis	0.000349	0.000712	CcSEcCtD
Baclofen—Decreased appetite—Pamidronate—osteoporosis	0.000349	0.000711	CcSEcCtD
Baclofen—Mental disorder—Estradiol—osteoporosis	0.000348	0.00071	CcSEcCtD
Baclofen—Dizziness—Alendronate—osteoporosis	0.000348	0.000709	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—P4HB—osteoporosis	0.000348	0.00456	CbGpPWpGaD
Baclofen—Shock—Conjugated Estrogens—osteoporosis	0.000347	0.000708	CcSEcCtD
Baclofen—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000346	0.000706	CcSEcCtD
Baclofen—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000346	0.000706	CcSEcCtD
Baclofen—Malnutrition—Estradiol—osteoporosis	0.000346	0.000706	CcSEcCtD
Baclofen—Fatigue—Pamidronate—osteoporosis	0.000346	0.000705	CcSEcCtD
Baclofen—Gastrointestinal pain—Risedronate—osteoporosis	0.000345	0.000704	CcSEcCtD
Baclofen—Tachycardia—Conjugated Estrogens—osteoporosis	0.000344	0.000702	CcSEcCtD
Baclofen—Urticaria—Ethinyl Estradiol—osteoporosis	0.000344	0.000701	CcSEcCtD
Baclofen—Constipation—Pamidronate—osteoporosis	0.000343	0.0007	CcSEcCtD
Baclofen—Pain—Pamidronate—osteoporosis	0.000343	0.0007	CcSEcCtD
Baclofen—Diarrhoea—Calcitriol—osteoporosis	0.000343	0.0007	CcSEcCtD
Baclofen—Skin disorder—Conjugated Estrogens—osteoporosis	0.000343	0.000699	CcSEcCtD
Baclofen—Hypotension—Zoledronate—osteoporosis	0.000342	0.000698	CcSEcCtD
Baclofen—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000342	0.000698	CcSEcCtD
Baclofen—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000342	0.000698	CcSEcCtD
Baclofen—Dizziness—Raloxifene—osteoporosis	0.000342	0.000698	CcSEcCtD
Baclofen—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000341	0.000696	CcSEcCtD
Baclofen—Flatulence—Estradiol—osteoporosis	0.000341	0.000695	CcSEcCtD
Baclofen—Vomiting—Estropipate—osteoporosis	0.000339	0.000693	CcSEcCtD
Baclofen—Dysgeusia—Estradiol—osteoporosis	0.000339	0.000691	CcSEcCtD
Baclofen—Dizziness—Ibandronate—osteoporosis	0.000339	0.000691	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—PTH—osteoporosis	0.000338	0.00443	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—WNT1—osteoporosis	0.000338	0.00443	CbGpPWpGaD
Baclofen—Rash—Estropipate—osteoporosis	0.000337	0.000687	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—PTHLH—osteoporosis	0.000337	0.00441	CbGpPWpGaD
Baclofen—Dermatitis—Estropipate—osteoporosis	0.000336	0.000686	CcSEcCtD
Baclofen—Anorexia—Conjugated Estrogens—osteoporosis	0.000336	0.000686	CcSEcCtD
Baclofen—Urticaria—Risedronate—osteoporosis	0.000335	0.000684	CcSEcCtD
Baclofen—Back pain—Estradiol—osteoporosis	0.000335	0.000683	CcSEcCtD
Baclofen—Headache—Estropipate—osteoporosis	0.000334	0.000682	CcSEcCtD
Baclofen—Vomiting—Alendronate—osteoporosis	0.000334	0.000682	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000334	0.000681	CcSEcCtD
Baclofen—Abdominal pain—Risedronate—osteoporosis	0.000334	0.00068	CcSEcCtD
Baclofen—Body temperature increased—Risedronate—osteoporosis	0.000334	0.00068	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—RAP1A—osteoporosis	0.000332	0.00436	CbGpPWpGaD
Baclofen—Rash—Alendronate—osteoporosis	0.000332	0.000676	CcSEcCtD
Baclofen—Insomnia—Zoledronate—osteoporosis	0.000331	0.000676	CcSEcCtD
Baclofen—Dermatitis—Alendronate—osteoporosis	0.000331	0.000676	CcSEcCtD
Baclofen—Feeling abnormal—Pamidronate—osteoporosis	0.000331	0.000674	CcSEcCtD
Baclofen—Hypotension—Conjugated Estrogens—osteoporosis	0.00033	0.000673	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—MGLL—osteoporosis	0.00033	0.00432	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CNR2—osteoporosis	0.00033	0.00432	CbGpPWpGaD
Baclofen—Headache—Alendronate—osteoporosis	0.000329	0.000672	CcSEcCtD
Baclofen—Paraesthesia—Zoledronate—osteoporosis	0.000329	0.000671	CcSEcCtD
Baclofen—Vomiting—Raloxifene—osteoporosis	0.000329	0.000671	CcSEcCtD
Baclofen—Gastrointestinal pain—Pamidronate—osteoporosis	0.000328	0.000669	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—ADCY5—osteoporosis	0.000327	0.00429	CbGpPWpGaD
Baclofen—Dyspnoea—Zoledronate—osteoporosis	0.000327	0.000666	CcSEcCtD
Baclofen—Rash—Raloxifene—osteoporosis	0.000326	0.000665	CcSEcCtD
Baclofen—Dermatitis—Raloxifene—osteoporosis	0.000326	0.000665	CcSEcCtD
Baclofen—Somnolence—Zoledronate—osteoporosis	0.000326	0.000664	CcSEcCtD
Baclofen—Vomiting—Ibandronate—osteoporosis	0.000326	0.000664	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—NFATC1—osteoporosis	0.000324	0.00425	CbGpPWpGaD
Baclofen—Tremor—Estradiol—osteoporosis	0.000324	0.000661	CcSEcCtD
Baclofen—Headache—Raloxifene—osteoporosis	0.000324	0.000661	CcSEcCtD
Baclofen—Rash—Ibandronate—osteoporosis	0.000323	0.000659	CcSEcCtD
Baclofen—Dermatitis—Ibandronate—osteoporosis	0.000323	0.000658	CcSEcCtD
Baclofen—Dyspepsia—Zoledronate—osteoporosis	0.000323	0.000658	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—DKK1—osteoporosis	0.000322	0.00422	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—LRP5—osteoporosis	0.000322	0.00422	CbGpPWpGaD
Baclofen—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000321	0.000656	CcSEcCtD
Baclofen—Ill-defined disorder—Estradiol—osteoporosis	0.000321	0.000655	CcSEcCtD
Baclofen—Headache—Ibandronate—osteoporosis	0.000321	0.000654	CcSEcCtD
Baclofen—Insomnia—Conjugated Estrogens—osteoporosis	0.000319	0.000651	CcSEcCtD
Baclofen—Vomiting—Calcitriol—osteoporosis	0.000319	0.00065	CcSEcCtD
Baclofen—Decreased appetite—Zoledronate—osteoporosis	0.000319	0.00065	CcSEcCtD
Baclofen—Agitation—Estradiol—osteoporosis	0.000318	0.000649	CcSEcCtD
Baclofen—Nausea—Estropipate—osteoporosis	0.000317	0.000647	CcSEcCtD
Baclofen—Body temperature increased—Pamidronate—osteoporosis	0.000317	0.000647	CcSEcCtD
Baclofen—Abdominal pain—Pamidronate—osteoporosis	0.000317	0.000647	CcSEcCtD
Baclofen—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000317	0.000646	CcSEcCtD
Baclofen—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000316	0.000645	CcSEcCtD
Baclofen—Rash—Calcitriol—osteoporosis	0.000316	0.000645	CcSEcCtD
Baclofen—Fatigue—Zoledronate—osteoporosis	0.000316	0.000644	CcSEcCtD
Baclofen—Dermatitis—Calcitriol—osteoporosis	0.000316	0.000644	CcSEcCtD
Baclofen—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000315	0.000642	CcSEcCtD
Baclofen—Headache—Calcitriol—osteoporosis	0.000314	0.000641	CcSEcCtD
Baclofen—Somnolence—Conjugated Estrogens—osteoporosis	0.000314	0.00064	CcSEcCtD
Baclofen—Pain—Zoledronate—osteoporosis	0.000313	0.000639	CcSEcCtD
Baclofen—Constipation—Zoledronate—osteoporosis	0.000313	0.000639	CcSEcCtD
Baclofen—Nausea—Alendronate—osteoporosis	0.000312	0.000637	CcSEcCtD
Baclofen—Malaise—Estradiol—osteoporosis	0.000312	0.000636	CcSEcCtD
Baclofen—Vertigo—Estradiol—osteoporosis	0.000311	0.000634	CcSEcCtD
Baclofen—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000311	0.000634	CcSEcCtD
Baclofen—Asthenia—Ethinyl Estradiol—osteoporosis	0.000311	0.000633	CcSEcCtD
Baclofen—Syncope—Estradiol—osteoporosis	0.00031	0.000633	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—WNT1—osteoporosis	0.00031	0.00406	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—LRP6—osteoporosis	0.000308	0.00403	CbGpPWpGaD
Baclofen—Nausea—Raloxifene—osteoporosis	0.000307	0.000627	CcSEcCtD
Baclofen—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000307	0.000626	CcSEcCtD
Baclofen—Pruritus—Ethinyl Estradiol—osteoporosis	0.000306	0.000625	CcSEcCtD
Baclofen—Palpitations—Estradiol—osteoporosis	0.000306	0.000624	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—PTHLH—osteoporosis	0.000306	0.00401	CbGpPWpGaD
Baclofen—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000305	0.000621	CcSEcCtD
Baclofen—Fatigue—Conjugated Estrogens—osteoporosis	0.000304	0.000621	CcSEcCtD
Baclofen—Nausea—Ibandronate—osteoporosis	0.000304	0.00062	CcSEcCtD
Baclofen—Loss of consciousness—Estradiol—osteoporosis	0.000304	0.00062	CcSEcCtD
Baclofen—Asthenia—Risedronate—osteoporosis	0.000303	0.000618	CcSEcCtD
Baclofen—Feeling abnormal—Zoledronate—osteoporosis	0.000302	0.000616	CcSEcCtD
Baclofen—Constipation—Conjugated Estrogens—osteoporosis	0.000302	0.000615	CcSEcCtD
Baclofen—Pain—Conjugated Estrogens—osteoporosis	0.000302	0.000615	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—FGA—osteoporosis	0.000301	0.00395	CbGpPWpGaD
Baclofen—Gastrointestinal pain—Zoledronate—osteoporosis	0.0003	0.000611	CcSEcCtD
Baclofen—Hypertension—Estradiol—osteoporosis	0.000299	0.000609	CcSEcCtD
Baclofen—Pruritus—Risedronate—osteoporosis	0.000299	0.000609	CcSEcCtD
Baclofen—Nausea—Calcitriol—osteoporosis	0.000298	0.000607	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—ADCY5—osteoporosis	0.000297	0.00389	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—CALCA—osteoporosis	0.000296	0.00388	CbGpPWpGaD
Baclofen—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000296	0.000604	CcSEcCtD
Baclofen—Myalgia—Estradiol—osteoporosis	0.000295	0.000601	CcSEcCtD
Baclofen—Chest pain—Estradiol—osteoporosis	0.000295	0.000601	CcSEcCtD
Baclofen—Anxiety—Estradiol—osteoporosis	0.000294	0.000599	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000293	0.000597	CcSEcCtD
Baclofen—Urticaria—Zoledronate—osteoporosis	0.000291	0.000594	CcSEcCtD
Baclofen—Discomfort—Estradiol—osteoporosis	0.000291	0.000594	CcSEcCtD
Baclofen—Body temperature increased—Zoledronate—osteoporosis	0.00029	0.000591	CcSEcCtD
Baclofen—Abdominal pain—Zoledronate—osteoporosis	0.00029	0.000591	CcSEcCtD
Baclofen—Diarrhoea—Risedronate—osteoporosis	0.000289	0.000589	CcSEcCtD
Baclofen—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000288	0.000589	CcSEcCtD
Baclofen—Dry mouth—Estradiol—osteoporosis	0.000288	0.000588	CcSEcCtD
Baclofen—Asthenia—Pamidronate—osteoporosis	0.000288	0.000587	CcSEcCtD
Baclofen—Dizziness—Ethinyl Estradiol—osteoporosis	0.000286	0.000584	CcSEcCtD
Baclofen—Confusional state—Estradiol—osteoporosis	0.000285	0.000581	CcSEcCtD
Baclofen—Pruritus—Pamidronate—osteoporosis	0.000284	0.000579	CcSEcCtD
Baclofen—Oedema—Estradiol—osteoporosis	0.000282	0.000576	CcSEcCtD
Baclofen—Infection—Estradiol—osteoporosis	0.000281	0.000572	CcSEcCtD
Baclofen—Urticaria—Conjugated Estrogens—osteoporosis	0.00028	0.000572	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—PTHLH—osteoporosis	0.00028	0.00367	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—BMP2—osteoporosis	0.00028	0.00367	CbGpPWpGaD
Baclofen—Dizziness—Risedronate—osteoporosis	0.000279	0.000569	CcSEcCtD
Baclofen—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000279	0.000569	CcSEcCtD
Baclofen—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000279	0.000569	CcSEcCtD
Baclofen—Shock—Estradiol—osteoporosis	0.000278	0.000567	CcSEcCtD
Baclofen—Nervous system disorder—Estradiol—osteoporosis	0.000277	0.000565	CcSEcCtD
Baclofen—Tachycardia—Estradiol—osteoporosis	0.000276	0.000562	CcSEcCtD
Baclofen—Vomiting—Ethinyl Estradiol—osteoporosis	0.000275	0.000561	CcSEcCtD
Baclofen—Diarrhoea—Pamidronate—osteoporosis	0.000274	0.00056	CcSEcCtD
Baclofen—GABBR1—GPCR ligand binding—POMC—osteoporosis	0.000274	0.0036	CbGpPWpGaD
Baclofen—Skin disorder—Estradiol—osteoporosis	0.000274	0.000559	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—FGB—osteoporosis	0.000274	0.00359	CbGpPWpGaD
Baclofen—Hyperhidrosis—Estradiol—osteoporosis	0.000273	0.000557	CcSEcCtD
Baclofen—Rash—Ethinyl Estradiol—osteoporosis	0.000273	0.000557	CcSEcCtD
Baclofen—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000273	0.000556	CcSEcCtD
Baclofen—Headache—Ethinyl Estradiol—osteoporosis	0.000271	0.000553	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—CALCA—osteoporosis	0.000269	0.00353	CbGpPWpGaD
Baclofen—Vomiting—Risedronate—osteoporosis	0.000268	0.000547	CcSEcCtD
Baclofen—Rash—Risedronate—osteoporosis	0.000266	0.000543	CcSEcCtD
Baclofen—Dermatitis—Risedronate—osteoporosis	0.000266	0.000542	CcSEcCtD
Baclofen—Dizziness—Pamidronate—osteoporosis	0.000265	0.000541	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—PSMA5—osteoporosis	0.000265	0.00347	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PSMA2—osteoporosis	0.000265	0.00347	CbGpPWpGaD
Baclofen—Headache—Risedronate—osteoporosis	0.000264	0.000539	CcSEcCtD
Baclofen—Asthenia—Zoledronate—osteoporosis	0.000263	0.000536	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—TLN1—osteoporosis	0.00026	0.0034	CbGpPWpGaD
Baclofen—Pruritus—Zoledronate—osteoporosis	0.000259	0.000529	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000257	0.000525	CcSEcCtD
Baclofen—Nausea—Ethinyl Estradiol—osteoporosis	0.000257	0.000524	CcSEcCtD
Baclofen—Insomnia—Estradiol—osteoporosis	0.000255	0.000521	CcSEcCtD
Baclofen—Vomiting—Pamidronate—osteoporosis	0.000255	0.00052	CcSEcCtD
Baclofen—Paraesthesia—Estradiol—osteoporosis	0.000254	0.000517	CcSEcCtD
Baclofen—Asthenia—Conjugated Estrogens—osteoporosis	0.000253	0.000516	CcSEcCtD
Baclofen—Rash—Pamidronate—osteoporosis	0.000253	0.000516	CcSEcCtD
Baclofen—Dermatitis—Pamidronate—osteoporosis	0.000253	0.000515	CcSEcCtD
Baclofen—Dyspnoea—Estradiol—osteoporosis	0.000252	0.000514	CcSEcCtD
Baclofen—Headache—Pamidronate—osteoporosis	0.000251	0.000513	CcSEcCtD
Baclofen—Somnolence—Estradiol—osteoporosis	0.000251	0.000512	CcSEcCtD
Baclofen—Diarrhoea—Zoledronate—osteoporosis	0.000251	0.000511	CcSEcCtD
Baclofen—Nausea—Risedronate—osteoporosis	0.000251	0.000511	CcSEcCtD
Baclofen—Pruritus—Conjugated Estrogens—osteoporosis	0.00025	0.000509	CcSEcCtD
Baclofen—Dyspepsia—Estradiol—osteoporosis	0.000249	0.000507	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—CALCA—osteoporosis	0.000247	0.00323	CbGpPWpGaD
Baclofen—Decreased appetite—Estradiol—osteoporosis	0.000245	0.000501	CcSEcCtD
Baclofen—Gastrointestinal disorder—Estradiol—osteoporosis	0.000244	0.000497	CcSEcCtD
Baclofen—Fatigue—Estradiol—osteoporosis	0.000243	0.000497	CcSEcCtD
Baclofen—Dizziness—Zoledronate—osteoporosis	0.000242	0.000494	CcSEcCtD
Baclofen—Pain—Estradiol—osteoporosis	0.000241	0.000493	CcSEcCtD
Baclofen—Constipation—Estradiol—osteoporosis	0.000241	0.000493	CcSEcCtD
Baclofen—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000241	0.000492	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—POMC—osteoporosis	0.000241	0.00315	CbGpPWpGaD
Baclofen—Nausea—Pamidronate—osteoporosis	0.000238	0.000486	CcSEcCtD
Baclofen—Dizziness—Conjugated Estrogens—osteoporosis	0.000233	0.000476	CcSEcCtD
Baclofen—Vomiting—Zoledronate—osteoporosis	0.000233	0.000475	CcSEcCtD
Baclofen—Feeling abnormal—Estradiol—osteoporosis	0.000233	0.000475	CcSEcCtD
Baclofen—Rash—Zoledronate—osteoporosis	0.000231	0.000471	CcSEcCtD
Baclofen—Gastrointestinal pain—Estradiol—osteoporosis	0.000231	0.000471	CcSEcCtD
Baclofen—Dermatitis—Zoledronate—osteoporosis	0.000231	0.000471	CcSEcCtD
Baclofen—Headache—Zoledronate—osteoporosis	0.00023	0.000468	CcSEcCtD
Baclofen—Vomiting—Conjugated Estrogens—osteoporosis	0.000224	0.000458	CcSEcCtD
Baclofen—Urticaria—Estradiol—osteoporosis	0.000224	0.000458	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—KL—osteoporosis	0.000224	0.00294	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—P4HB—osteoporosis	0.000224	0.00294	CbGpPWpGaD
Baclofen—Abdominal pain—Estradiol—osteoporosis	0.000223	0.000455	CcSEcCtD
Baclofen—Body temperature increased—Estradiol—osteoporosis	0.000223	0.000455	CcSEcCtD
Baclofen—Rash—Conjugated Estrogens—osteoporosis	0.000222	0.000454	CcSEcCtD
Baclofen—Dermatitis—Conjugated Estrogens—osteoporosis	0.000222	0.000453	CcSEcCtD
Baclofen—Headache—Conjugated Estrogens—osteoporosis	0.000221	0.000451	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—POMC—osteoporosis	0.000219	0.00286	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PTH—osteoporosis	0.000218	0.00286	CbGpPWpGaD
Baclofen—Nausea—Zoledronate—osteoporosis	0.000218	0.000444	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—RAP1A—osteoporosis	0.000214	0.00281	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—IL6R—osteoporosis	0.000213	0.00279	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CNR2—osteoporosis	0.000212	0.00278	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—ADCY5—osteoporosis	0.000211	0.00276	CbGpPWpGaD
Baclofen—Nausea—Conjugated Estrogens—osteoporosis	0.00021	0.000427	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—NFATC1—osteoporosis	0.000209	0.00274	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—DKK1—osteoporosis	0.000207	0.00272	CbGpPWpGaD
Baclofen—Asthenia—Estradiol—osteoporosis	0.000203	0.000413	CcSEcCtD
Baclofen—Pruritus—Estradiol—osteoporosis	0.0002	0.000408	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—WNT1—osteoporosis	0.0002	0.00262	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—FGA—osteoporosis	0.000194	0.00255	CbGpPWpGaD
Baclofen—Diarrhoea—Estradiol—osteoporosis	0.000193	0.000394	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—ADCY5—osteoporosis	0.000191	0.00251	CbGpPWpGaD
Baclofen—Dizziness—Estradiol—osteoporosis	0.000187	0.000381	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—PTHLH—osteoporosis	0.000181	0.00237	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—BMP2—osteoporosis	0.000181	0.00237	CbGpPWpGaD
Baclofen—Vomiting—Estradiol—osteoporosis	0.00018	0.000366	CcSEcCtD
Baclofen—Rash—Estradiol—osteoporosis	0.000178	0.000363	CcSEcCtD
Baclofen—Dermatitis—Estradiol—osteoporosis	0.000178	0.000363	CcSEcCtD
Baclofen—Headache—Estradiol—osteoporosis	0.000177	0.000361	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—FGB—osteoporosis	0.000177	0.00232	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—ADCY5—osteoporosis	0.000175	0.0023	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PSMA2—osteoporosis	0.000171	0.00224	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PSMA5—osteoporosis	0.000171	0.00224	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—SPP1—osteoporosis	0.00017	0.00222	CbGpPWpGaD
Baclofen—Nausea—Estradiol—osteoporosis	0.000168	0.000342	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—CALCA—osteoporosis	0.000159	0.00208	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—POMC—osteoporosis	0.000155	0.00203	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IRS2—osteoporosis	0.000154	0.00201	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—LEP—osteoporosis	0.00015	0.00197	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—KL—osteoporosis	0.000144	0.00189	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—ESR1—osteoporosis	0.000143	0.00188	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—POMC—osteoporosis	0.000141	0.00185	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—IL6R—osteoporosis	0.000137	0.0018	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IRS1—osteoporosis	0.000134	0.00176	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—ADCY5—osteoporosis	0.000133	0.00174	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—POMC—osteoporosis	0.000129	0.00169	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IL6R—osteoporosis	0.000126	0.00165	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IGF1—osteoporosis	0.000124	0.00163	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—ADCY5—osteoporosis	0.000113	0.00148	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SPP1—osteoporosis	0.000109	0.00143	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IRS2—osteoporosis	9.89e-05	0.0013	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—LEP—osteoporosis	9.68e-05	0.00127	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—IL6—osteoporosis	9.49e-05	0.00124	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—ESR1—osteoporosis	9.24e-05	0.00121	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IRS1—osteoporosis	8.64e-05	0.00113	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—POMC—osteoporosis	8.32e-05	0.00109	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IL6R—osteoporosis	8.11e-05	0.00106	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IGF1—osteoporosis	8e-05	0.00105	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MYC—osteoporosis	7.46e-05	0.000978	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—TGFB1—osteoporosis	7.44e-05	0.000975	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—IL6—osteoporosis	6.12e-05	0.000802	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IL6—osteoporosis	5.61e-05	0.000735	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MYC—osteoporosis	4.81e-05	0.00063	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—TGFB1—osteoporosis	4.8e-05	0.000629	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IL6—osteoporosis	3.61e-05	0.000474	CbGpPWpGaD
